tDCS trial for musculoskeletal and spinal cord diseases

Not Applicable

Recruiting

• Conditions: Cervical spondylotic myelopathy, Cervical spondylotic amyotrophy, Lumbar spinal canal stenosis, Rota; Cervical spondylotic myelopathy, Cervical spondylotic amyotrophy, Lumbar spinal canal stenosis, Rotator cuff tear, Frozen shoulder; C10.228.854, C26.761.340, C05.550.251

• Registration Number: JPRN-jRCTs032180298
• Lead Sponsor: Shitara Hitoshi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-15
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

1)Participants who can be obtained informed consent from themselves
2)Currently, taking no medical treatment for serious health reasons such as mental and neurological diseases.
3)Health subjects or Patients with cervical spondylotic myelopathy, cervical spondylotic amyotrophy, lumbar spinal canal stenosis, rotator cuff tear, or frozen shoulder
4)Dominant hand or foot is the right
5)No contraindication on the implementation of transcranial magnetic stimulation (TMS) or tDCS

Exclusion Criteria

1)Patients with complication of more than one disease which is cervical spondylotic myelopathy, cervical spondylotic amyotrophy, lumbar spinal canal stenosis, rotator cuff tear, or frozen shoulder
2)Patients with obvious resting pain
3)Suspected women who are pregnancy
4)Complete paralysis
5)Participants who have any contraindications on the implementation of TMS or TMS
6)Participants who have any contraindications for undergoing an MRI scan
7)Participants who are judged unsuitable subjects by a doctor

Study & Design

• Study Type: Interventional
• Study Design: Not specified